{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:54:01Z","timestamp":1775908441827,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myotonic dystrophy type 1 (DM1) is the most common type of adult muscular dystrophy caused by the expanded triple-nucleotides (CUG) repeats. Myoblast in DM1 displayed many defects, including defective myoblast differentiation, ribonuclear foci, and aberrant alternative splicing. Despite many were revealed to function in DM1, microRNAs that regulated DM1 via directly targeting the expanded CUG repeats were rarely reported. Here we discovered that miR-322\/-503 rescued myoblast defects in DM1 cell model by targeting the expanded CUG repeats. First, we studied the function of miR-322\/-503 in normal C2C12 myoblast cells. Downregulation of miR-322\/-503 significantly hindered the myoblast differentiation, while miR-322\/-503 overexpression promoted the process. Next, we examined the role of miR-322\/-503 in the DM1 C2C12 cell model. miR-322\/-503 was downregulated in the differentiation of DM1 C2C12 cells. When we introduced ectopic miR-322\/-503 expression into DM1 C2C12 cells, myoblast defects were almost fully rescued, marked by significant improvements of myoblast differentiation and repressions of ribonuclear foci formation and aberrant alternative splicing. Then we investigated the downstream mechanism of miR-322\/-503 in DM1. Agreeing with our previous work, Celf1 was proven to be miR-322\/-503\u2032s target. Celf1 knockdown partially reproduced miR-322\/-503\u2032s function in rescuing DM1 C2C12 differentiation but was unable to repress ribonuclear foci, suggesting other targets of miR-322\/-503 existed in the DM1 C2C12 cells. As the seed regions of miR-322 and miR-503 were complementary to the CUG repeats, we hypothesized that the CUG repeats were the target of miR-322\/-503. Through expression tests, reporter assays, and colocalization staining, miR-322\/-503 was proved to directly and specifically target the expanded CUG repeats in the DM1 cell model rather than the shorter ones in normal cells. Those results implied a potential therapeutic function of miR-322\/-503 on DM1, which needed further investigations in the future.<\/jats:p>","DOI":"10.1038\/s41419-020-03112-6","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:02:38Z","timestamp":1603346558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["miR-322\/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6116-635X","authenticated-orcid":false,"given":"Xiaopeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"3112_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd, B. & Krahe, R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 11, 891\u2013905 (2012).","journal-title":"Lancet Neurol."},{"key":"3112_CR2","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","volume":"19","author":"JW Miller","year":"2000","unstructured":"Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439\u20134448 (2000).","journal-title":"EMBO J."},{"key":"3112_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","volume":"28","author":"NM Kuyumcu-Martinez","year":"2007","unstructured":"Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68\u201378 (2007).","journal-title":"Mol. Cell"},{"key":"3112_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1101\/gad.1894310","volume":"24","author":"A Kalsotra","year":"2010","unstructured":"Kalsotra, A., Wang, K., Li, P. F. & Cooper, T. A. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 24, 653\u2013658 (2010).","journal-title":"Genes Dev."},{"key":"3112_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"BN Charlet","year":"2002","unstructured":"Charlet, B. N. et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45\u201353 (2002).","journal-title":"Mol. Cell"},{"key":"3112_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi, A. et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35\u201344 (2002).","journal-title":"Mol. Cell"},{"key":"3112_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng704","volume":"29","author":"RS Savkur","year":"2001","unstructured":"Savkur, R. S., Philips, A. V. & Cooper, T. A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40\u201347 (2001).","journal-title":"Nat. Genet."},{"key":"3112_CR8","doi-asserted-by":"publisher","first-page":"13570","DOI":"10.1073\/pnas.1308806110","volume":"110","author":"Z Gao","year":"2013","unstructured":"Gao, Z. & Cooper, T. A. Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy. Proc. Natl Acad. Sci. USA 110, 13570\u201313575 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.280.5364.737","volume":"280","author":"AV Philips","year":"1998","unstructured":"Philips, A. V., Timchenko, L. T. & Cooper, T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737\u2013741 (1998).","journal-title":"Science"},{"key":"3112_CR10","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/sj.emboj.7600300","volume":"23","author":"TH Ho","year":"2004","unstructured":"Ho, T. H. et al. Muscleblind proteins regulate alternative splicing. EMBO J. 23, 3103\u20133112 (2004).","journal-title":"EMBO J."},{"key":"3112_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/hmg\/ddi162","volume":"14","author":"TH Ho","year":"2005","unstructured":"Ho, T. H., Bundman, D., Armstrong, D. L. & Cooper, T. A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 14, 1539\u20131547 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"3112_CR12","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978\u20131980 (2003).","journal-title":"Science"},{"key":"3112_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/hmg\/ddp570","volume":"19","author":"M Koshelev","year":"2010","unstructured":"Koshelev, M., Sarma, S., Price, R. E., Wehrens, X. H. & Cooper, T. A. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum. Mol. Genet. 19, 1066\u20131075 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"3112_CR14","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1093\/hmg\/ddq277","volume":"19","author":"AJ Ward","year":"2010","unstructured":"Ward, A. J., Rimer, M., Killian, J. M., Dowling, J. J. & Cooper, T. A. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum. Mol. Genet. 19, 3614\u20133622 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"3112_CR15","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1074\/jbc.M312923200","volume":"279","author":"NA Timchenko","year":"2004","unstructured":"Timchenko, N. A. et al. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 279, 13129\u201313139 (2004).","journal-title":"J. Biol. Chem."},{"key":"3112_CR16","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1128\/MCB.21.20.6927-6938.2001","volume":"21","author":"NA Timchenko","year":"2001","unstructured":"Timchenko, N. A., Iakova, P., Cai, Z. J., Smith, J. R. & Timchenko, L. T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell Biol. 21, 6927\u20136938 (2001).","journal-title":"Mol. Cell Biol."},{"key":"3112_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.bbadis.2015.04.010","volume":"1852","author":"X Peng","year":"2015","unstructured":"Peng, X. et al. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity. Biochim. Biophys. Acta 1852, 1490\u20131497 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"3112_CR18","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1172\/JCI37976","volume":"119","author":"GS Wang","year":"2009","unstructured":"Wang, G. S. et al. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. J. Clin. Investig. 119, 3797\u20133806 (2009).","journal-title":"J. Clin. Investig."},{"key":"3112_CR19","doi-asserted-by":"publisher","first-page":"11748","DOI":"10.1073\/pnas.0604970103","volume":"103","author":"RN Kanadia","year":"2006","unstructured":"Kanadia, R. N. et al. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl Acad. Sci. USA 103, 11748\u201311753 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.gt.3301955","volume":"10","author":"D Furling","year":"2003","unstructured":"Furling, D. et al. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther. 10, 795\u2013802 (2003).","journal-title":"Gene Ther."},{"key":"3112_CR21","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1073\/pnas.1901484116","volume":"116","author":"AJ Angelbello","year":"2019","unstructured":"Angelbello, A. J. et al. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model. Proc. Natl Acad. Sci. USA 116, 7799\u20137804 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR22","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1073\/pnas.0903234106","volume":"106","author":"MB Warf","year":"2009","unstructured":"Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A. & Berglund, J. A. Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl Acad. Sci. USA 106, 18551\u201318556 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.omtn.2017.10.006","volume":"9","author":"C Provenzano","year":"2017","unstructured":"Provenzano, C. et al. CRISPR\/Cas9-mediated deletion of CTG expansions recovers normal phenotype in myogenic cells derived from myotonic dystrophy 1 patients. Mol. Ther. Nucleic Acids 9, 337\u2013348 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3112_CR24","doi-asserted-by":"publisher","first-page":"11866","DOI":"10.1073\/pnas.1018213108","volume":"108","author":"A Garcia-Lopez","year":"2011","unstructured":"Garcia-Lopez, A., Llamusi, B., Orzaez, M., Perez-Paya, E. & Artero, R. D. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models. Proc. Natl Acad. Sci. USA 108, 11866\u201311871 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/hmg\/dds478","volume":"22","author":"JM Fernandez-Costa","year":"2013","unstructured":"Fernandez-Costa, J. M. et al. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients. Hum. Mol. Genet. 22, 704\u2013716 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"3112_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep36230","volume":"6","author":"E Cerro-Herreros","year":"2016","unstructured":"Cerro-Herreros, E., Fernandez-Costa, J. M., Sabater-Arcis, M., Llamusi, B. & Artero, R. Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila. Sci. Rep. 6, 36230 (2016).","journal-title":"Sci. Rep."},{"key":"3112_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/01616412.2018.1493963","volume":"41","author":"W Dong","year":"2019","unstructured":"Dong, W. et al. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy. Neurol. Res. 41, 9\u201318 (2019).","journal-title":"Neurol. Res."},{"key":"3112_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.celrep.2013.12.025","volume":"6","author":"A Kalsotra","year":"2014","unstructured":"Kalsotra, A. et al. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. Cell Rep. 6, 336\u2013345 (2014).","journal-title":"Cell Rep."},{"key":"3112_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nsmb.2067","volume":"18","author":"F Rau","year":"2011","unstructured":"Rau, F. et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat. Struct. Mol. Biol. 18, 840\u2013845 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3112_CR30","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1093\/nar\/gkv849","volume":"43","author":"E Koscianska","year":"2015","unstructured":"Koscianska, E., Witkos, T. M., Kozlowska, E., Wojciechowska, M. & Krzyzosiak, W. J. Cooperation meets competition in microRNA-mediated DMPK transcript regulation. Nucleic Acids Res. 43, 9500\u20139518 (2015).","journal-title":"Nucleic Acids Res."},{"key":"3112_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1101\/gad.237404.114","volume":"28","author":"D Llobet-Navas","year":"2014","unstructured":"Llobet-Navas, D. et al. The miR-424(322)\/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev. 28, 765\u2013782 (2014).","journal-title":"Genes Dev."},{"key":"3112_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1101\/gad.292318.116","volume":"31","author":"R Rodriguez-Barrueco","year":"2017","unstructured":"Rodriguez-Barrueco, R. et al. miR-424(322)\/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy. Genes Dev. 31, 553\u2013566 (2017).","journal-title":"Genes Dev."},{"key":"3112_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11406","volume":"7","author":"S Xu","year":"2016","unstructured":"Xu, S. et al. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat. Commun. 7, 11406 (2016).","journal-title":"Nat. Commun."},{"key":"3112_CR34","doi-asserted-by":"publisher","unstructured":"Youn, S. W. et al. Modification of cardiac progenitor cell-derived exosomes by miR-322 provides protection against myocardial infarction through Nox2-dependent angiogenesis. Antioxidants (Basel) https:\/\/doi.org\/10.3390\/antiox8010018 (2019).","DOI":"10.3390\/antiox8010018"},{"key":"3112_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02852-4","volume":"7","author":"A Lee","year":"2017","unstructured":"Lee, A. et al. A PPARgamma-dependent miR-424\/503-CD40 axis regulates inflammation mediated angiogenesis. Sci. Rep. 7, 2528 (2017).","journal-title":"Sci. Rep."},{"key":"3112_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvx187","volume":"114","author":"R Baptista","year":"2018","unstructured":"Baptista, R. et al. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1. Cardiovasc. Res. 114, 53\u201364 (2018).","journal-title":"Cardiovasc. Res."},{"key":"3112_CR37","first-page":"2812","volume":"8","author":"L Yang","year":"2016","unstructured":"Yang, L., Song, S. & Lv, H. MicroRNA-322 protects hypoxia-induced apoptosis in cardiomyocytes via BDNF gene. Am. J. Transl. Res. 8, 2812\u20132819 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"3112_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bbadis.2016.01.010","volume":"1862","author":"A Marchand","year":"2016","unstructured":"Marchand, A. et al. miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice. Biochim. Biophys. Acta 1862, 611\u2013621 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"3112_CR39","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1073\/pnas.1608256113","volume":"113","author":"X Shen","year":"2016","unstructured":"Shen, X. et al. miR-322\/-503 cluster is expressed in the earliest cardiac progenitor cells and drives cardiomyocyte specification. Proc. Natl Acad. Sci. USA 113, 9551\u20139556 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3112_CR40","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1091\/mbc.e10-01-0062","volume":"21","author":"S Sarkar","year":"2010","unstructured":"Sarkar, S., Dey, B. K. & Dutta, A. MiR-322\/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol. Biol. Cell 21, 2138\u20132149 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"3112_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1432-5","volume":"10","author":"MJ Zhao","year":"2019","unstructured":"Zhao, M. J. et al. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation. Cell Death Dis. 10, 183 (2019).","journal-title":"Cell Death Dis."},{"key":"3112_CR42","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/hmg\/10.18.1879","volume":"10","author":"JD Amack","year":"2001","unstructured":"Amack, J. D. & Mahadevan, M. S. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet. 10, 1879\u20131887 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"3112_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-29","volume":"15","author":"PK Busk","year":"2014","unstructured":"Busk, P. K. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinform. 15, 29 (2014).","journal-title":"BMC Bioinform."},{"key":"3112_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-70","volume":"11","author":"I Balcells","year":"2011","unstructured":"Balcells, I., Cirera, S. & Busk, P. K. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol. 11, 70 (2011).","journal-title":"BMC Biotechnol."},{"key":"3112_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-1062-5_7","volume":"1182","author":"S Cirera","year":"2014","unstructured":"Cirera, S. & Busk, P. K. Quantification of miRNAs by a simple and specific qPCR method. Methods Mol. Biol. 1182, 73\u201381 (2014).","journal-title":"Methods Mol. Biol."},{"key":"3112_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.200206020","volume":"159","author":"JD Amack","year":"2002","unstructured":"Amack, J. D., Reagan, S. R. & Mahadevan, M. S. Mutant DMPK 3\u2019-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J. Cell Biol. 159, 419\u2013429 (2002).","journal-title":"J. Cell Biol."},{"key":"3112_CR47","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/cdd.2010.33","volume":"17","author":"E Loro","year":"2010","unstructured":"Loro, E. et al. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. Cell Death Differ. 17, 1315\u20131324 (2010).","journal-title":"Cell Death Differ."},{"key":"3112_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0925-4439(90)90006-B","volume":"1096","author":"AE Jacobs","year":"1990","unstructured":"Jacobs, A. E. et al. The calcium homeostasis and the membrane potential of cultured muscle cells from patients with myotonic dystrophy. Biochim. Biophys. Acta 1096, 14\u201319 (1990).","journal-title":"Biochim. Biophys. Acta"},{"key":"3112_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1083\/jcb.201108113","volume":"196","author":"A Ravel-Chapuis","year":"2012","unstructured":"Ravel-Chapuis, A. et al. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing. J. Cell Biol. 196, 699\u2013712 (2012).","journal-title":"J. Cell Biol."},{"key":"3112_CR50","doi-asserted-by":"publisher","unstructured":"Wu, J. et al. miR-503 suppresses the proliferation and metastasis of esophageal squamous cell carcinoma by triggering autophagy via PKA\/mTOR signaling. Int. J. Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4320 (2018).","DOI":"10.3892\/ijo.2018.4320"},{"key":"3112_CR51","first-page":"3515","volume":"22","author":"LJ Hou","year":"2018","unstructured":"Hou, L. J., Han, J. J. & Liu, Y. Up-regulation of microRNA-503 by high glucose reduces the migration and proliferation but promotes the apoptosis of human umbilical vein endothelial cells by inhibiting the expression of insulin-like growth factor-1 receptor. Eur. Rev. Med. Pharm. Sci. 22, 3515\u20133523 (2018).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"3112_CR52","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.bbrc.2018.07.084","volume":"503","author":"KH Min","year":"2018","unstructured":"Min, K. H., Yang, W. M. & Lee, W. Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes. Biochem. Biophys. Res. Commun. 503, 1587\u20131593 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3112_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.nmd.2014.02.005","volume":"24","author":"A Perfetti","year":"2014","unstructured":"Perfetti, A. et al. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul. Disord. 24, 509\u2013515 (2014).","journal-title":"Neuromuscul. Disord."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03112-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:31:17Z","timestamp":1670254277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03112-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["3112"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03112-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"891"}}